Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Double-expressor Lymphoma (DEL)”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Testing effectiveness (Phase 2)Looking for participantsNCT06891157
What this trial is testing

Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular Subtypes

Who this might be right for
ChidamideR-CHOP ChemotherapyDLBCL - Diffuse Large B Cell Lymphoma+1 more
The First Affiliated Hospital with Nanjing Medical University 148
Early research (Phase 1)Study completedNCT01742988
What this trial is testing

Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma

Who this might be right for
LymphomaRelapsed LymphomaRefractory Lymphoma+8 more
Curis, Inc. 106
Testing effectiveness (Phase 2)Looking for participantsNCT06674096
What this trial is testing

RLC Followed by CR-CHOP in Elderly Patients with Newly-diagnosed DEL

Who this might be right for
Double-expressor Lymphoma
Zhejiang Cancer Hospital 44
Large-scale testing (Phase 3)Not Yet RecruitingNCT07511114
What this trial is testing

A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping

Who this might be right for
DLBCL - Diffuse Large B Cell LymphomaDouble Expressor Lymphoma
Ruijin Hospital 156